We found a statistically significant difference in plasma fibulin-3 levels between patients with asbestos-related pleural changes (Group A) and those with mesothelioma (Group M), with higher levels observed in the mesothelioma group (p = 0.0132). Here, EFEMP1 is linked to mesothelioma.